UHC X EndTB strategy: working together to End TB

Meeting Organizer

Health Systems Research Institute (HSRI), Thailand

World Health Organization

Department of Medical Sciences, Ministry of Public Health

Department of Disease Control, Ministry of Public Health

Contact Person : Surakameth,

28 January 2020
09:00 - 17:30 hrs.
Venue : World Ballroom A, FL. 23
30 January 2020
09:00 - 17:30 hrs.
Venue : Lotus Suite 10

Open to All Participants


“The End TB Strategy” is the global strategy aiming to end TB epidemic. At the United Nations High-Level Meeting on 26th September 2018, heads of state and governments committed on TB Key targets for 2022. The critical objectives determined, by these leaders are to provide 1) Diagnosis and treatment of 40 million people with TB by 2022, 2) successfully treating 3.5 million children with TB by 2022, 3) Diagnosis and treatment of 1.5 million people with drug-resistant tuberculosis and 4) the treatment for preventive therapy in latent tuberculosis infection. Not only the health services packages, the adequate funding for tuberculosis researches are also required, but a draft strategy for tuberculosis research and innovations is also necessary for the tuberculosis control. This side meeting is the event to discuss the four objectives in the draft strategy for tuberculosis research and innovations and provide comment on the strategy to facilitate the strategy implementations in the member states. Universal health coverage is the crucial financing mechanisms in those high burden countries to ending tuberculosis. Thailand has recently update their tuberculosis treatment guideline and the benefit package for the universal health coverage schemes. The updated benefit packages included high sensitive diagnosis algorithm and treatment of latent tuberculosis infection. Using chest radiography as the first triage diagnostic tool for high-risk populations such as the prisoners and the contacts of tuberculosis, The improved benefits package for all forms tuberculosis include free drugs for the extensive drug resistance tuberculosis. To maximizing the benefits of health and development policies and systems, by engaging a broader cross-section of actors across government, communities and the private sector; and pursuing new scientific knowledge and innovations that can dramatically change TB prevention and care. The third pillar of the End TB strategy promotes that links upstream fundamental research to discovery and new tool development, and ultimately to operational and implementation research. The effective national TB research plan and research efforts adopting to the specific country needs are essential to achieve the goals. The application of the research outcomes into the national strategy toward ending TB should be discussed across the world.


1) To discuss and share the current financing of tuberculosis health care with Universal Health Coverage in various countries, focusing on the closing of funding gap. 2) To share the research experience and national research plan for End TB between Thailand and the other Asian countries and discuss new research plans and international research collaboration for the future. 3) To discuss and share the financing of tuberculosis research and the “draft strategy for tuberculosis research and innovation” 4) To discuss and share health economics researches on tuberculosis focusing on UHC